Literature DB >> 6416870

Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. V. The primary syngeneic sensitization is under I-A subregion control.

J Salamero, J Charreire.   

Abstract

The genetic control of in vitro primary syngeneic sensitization on monolayers of thyroid epithelial cells was investigated both at the level of the responder lymphocytes and that of stimulator thyroid epithelial cells using congenic resistant strains of mice. It clearly appears that similar to the in vivo model of experimental autoimmune thyroiditis induced by thyroglobulin and complete Freund's adjuvant, the optimal stimulation is found when compatibility between thyroid epithelial cells and responder lymphocytes occurs at the I-A subregion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416870     DOI: 10.1002/eji.1830131115

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  H-2E(k) expression influences thyroiditis induction by the thyroglobulin peptide (2495-2511).

Authors:  E Chronopoulou; G Carayanniotis
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells.

Authors:  I Todd; L J Hammond; R F James; M Feldmann; G F Bottazzo
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.

Authors:  I Todd; R Pujol-Borrell; B A Abdul-Karim; L J Hammond; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

5.  Interferon-gamma induces HLA-DR expression by thyroid epithelium.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; G F Bottazzo; M Feldmann
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.